By www.reliablemarketsize.com
Global Klebsiella Pneumoniae Infection Drug Market Insights And Forecast To 2031 Story
111
$ 4900
Klebsiella Pneumoniae Infection Drug Report report is categorised based on following features:
1. Global Market Players
2. Geopolitical regions
3. Consumer Insights
4. Technological advancement
5. Historic and Future Analysis of the Market
Acies Bio doo Appili Therapeutics Debiopharm International SA Evaxion Biotech ApS F. Hoffmann-La Roche Ltd FOB Synthesis Inc ImmunoClin Corp Innovation Pharmaceuticals Inc Kyorin Pharmaceutical Co Ltd Melinta Therapeutics Inc Nosopharm SAS Peptilogics Inc Pfizer Inc Phico Therapeutics Ltd Sarepta Therapeutics Inc Shionogi & Co Ltd Syntiron LLC Tetraphase Pharmaceuticals Inc